Literature DB >> 30818075

Quality of life in patients with multifocal motor neuropathy from Serbia.

Ivo Bozovic1, Stojan Peric1, Ivana Basta1, Aleksandra Kacar1, Ana Nikolic1, Bozidar Belanovic1, Dragana Lavrnic1, Vidosava Rakocevic-Stojanovic1, Zorica Stevic2.   

Abstract

INTRODUCTION AND AIM: Multifocal motor neuropathy (MMN) is a rare, chronic disorder with potentially severe and progressive disability, which may affect patients' quality of life (QoL). Since there is still small number of studies that predominantly investigated QoL in patients with MMN, we sought to analyze QoL in these patients.
MATERIALS AND METHODS: Our study comprised 17 patients diagnosed with MMN at the same clinic. Following scales were used: SF-36 questionnaire, INCAT disability scale, Krupp's Fatigue Severity scale, and Beck Depression Inventory.
RESULTS: Physical domains of QoL were slightly more affected than mental ones, but with no statistical significance (64.8 ± 22.3 vs. 70.0 ± 19.5, p > 0.05). Total SF-36 score was 69.2 ± 19.9. INCAT arm disability score at testing was found to correlate with the total SF-36 score (rho = -0.603, p < 0.05). INCAT arm disability score at diagnosis (rho = -0.57, p < 0.05) and at testing (rho = -0.48, p = 0.05) correlated with physical composite score (PCS). Disease duration (rho = -0.51, p < 0.05) and INCAT arm disability score at testing (rho = -0.60, p = 0.01) were associated with mental composite score (MCS).
CONCLUSION: QoL in patients with MMN was reduced, especially in physical domains. Although arm disability was the most significant parameter which affected QoL of MMN patients in both physical and mental aspects, longer disease duration should not be underestimated as a psychological burden for these patients.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disability; Multifocal motor neuropathy; Quality of life

Mesh:

Year:  2019        PMID: 30818075     DOI: 10.1016/j.jns.2019.02.029

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Valuing the "Burden" and Impact of Rare Diseases: A Scoping Review.

Authors:  Julien Delaye; Pasquale Cacciatore; Anna Kole
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

2.  Physical and Mental Aspects of Quality of Life in Patients With Charcot-Marie-Tooth Disease Type 1A.

Authors:  Vukan Ivanovic; Bogdan Bjelica; Aleksa Palibrk; Marija Brankovic; Ivo Bozovic; Ivana Basta; Andrija Savic; Vidosava Rakocevic Stojanovic; Aleksandra Kacar
Journal:  Front Neurol       Date:  2022-03-16       Impact factor: 4.003

3.  COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional Study.

Authors:  Eva-Maria Skoda; Mark Stettner; Venja Musche; Alexander Bäuerle; Lisa Jahre; Adam Schweda; Hannah Dinse; Sheila Moradian; Benjamin Weismüller; Madeleine Fink; Anna Wolters; Michael Fleischer; Christoph Kleinschnitz; Martin Teufel
Journal:  Neurol Ther       Date:  2022-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.